Skip to main content

Therapie und Verlauf von erworbenen Faktor VIII-Inhibitoren bei nicht-hämophilen Patienten

  • Conference paper
22. Hämophilie-Symposion Hamburg 1991

Zusammenfassung

Erworbene Inhibitoren gegen F.VIII: C können sowohl bei Patienten mit Grundkrankheiten als auch bei gesunden Personen sowie therapieinduziert bei Patienten mit Hämophilie A auftreten (1 -7).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Allain JP, Gaillandre, A, Frommel D (1981) Functional Study of Antibodies to Factor VIIL Thrombos Haemostas 45:285–289

    Google Scholar 

  • Green D, Lechner K (1981) A Survey of 215 Non-Hemophilic Patients with Inhibitors to Factor VIII. Thrombos Haemostas 45:200–203

    CAS  Google Scholar 

  • Scharrer I (1986) Erworbene Antikörper gegen Gerinnungsfaktoren. Hämostasiol 6:89–92

    Google Scholar 

  • Neidhardt B, Bartels O, Hahn B (1985) Hemmkörperhämophilie A post partum. DMW 20:799–802

    Article  Google Scholar 

  • Michels JJ, Bosch J et al (1978) Factor VIII Inhibitor Postpartum. Scand J Hematol 20:97–101

    Article  Google Scholar 

  • Lottenberg R, Kentro TB, Kitchens CS (1987) Acquired Hemophilia. Arch Intern Med 147:1077–1081

    Article  PubMed  CAS  Google Scholar 

  • Söhngen D, Köster W et al (1990) Three Cases of Acquired Factor VIII: C Inhibitors in Non-hemophilic Patients. Klin Wochenschr 68:1071–1075

    Article  PubMed  Google Scholar 

  • Kasper CK, Ewing NP (1986) Acquired Inhibitors of Plasma Coagulation Factors. J Med Technol 3:431–439

    CAS  Google Scholar 

  • Nilsson IM, Berntorp E, Zetterval O (1981) Induction of Immune Tolerance in Patients with Hemophilia and Antibodies to Factor VIII by Combined Treatment With Intravenous IgG, Cyclophosphamide and Factor VIII. N Engl J Med 15:947–950

    Google Scholar 

  • Seifried E, Gaedicke G et al (1984) The Treatment of Haemophilia A Inhibitor with High Dose Intravenous Immunoglobulin. Blut 48:397–401

    Article  PubMed  CAS  Google Scholar 

  • Regnault V, Rivat C, Vallet P (1987) A Potential New Procedure for Removing Anti-Factor VIII Antibodies from Hemophilic Plasma. Thrombos Res 45:51–57

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Störkel, F., Mondorf, W., Scharrer, I. (1992). Therapie und Verlauf von erworbenen Faktor VIII-Inhibitoren bei nicht-hämophilen Patienten. In: Landbeck, G., Scharrer, I., Schramm, W. (eds) 22. Hämophilie-Symposion Hamburg 1991. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77881-0_36

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-77881-0_36

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-56096-8

  • Online ISBN: 978-3-642-77881-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics